European Journal of Cancer
Volume 46, Issue 1 , Pages 56-71 , January 2010

ONCOPOOL – A European database for 16,944 cases of breast cancer

Received 9 June 2009 ,Revised 9 July 2009 ,Accepted 9 September 2009.

References 

  1. Henson DE, Reis L, Freedman LS, Carriaga M. Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer. 1991;68:2142–2149
  2. Ries LAGR, Henson DE, Harras A. Survival from breast cancer according to tumor size and nodal status. Surg Oncol Clin North Am. 1994;3:35–53
  3. Beral V, Hermon C, Reeves G, Peto R. Sudden fall in breast cancer death rates in England and Wales. Lancet. 1995;345:1642–1643
  4. Haybittle JL, Blamey RW, Elston CW, et al. A prognostic index in primary breast cancer. Br J Cancer. 1982;45:361–366
  5. Galea MH, Blamey RW, Elston CW, Ellis IO. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat. 1992;22:207–219
  6. Blamey RW, Ellis IO, Pinder SE, et al. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999. Eur J Cancer. 2007;43:1548–1555
  7. Blamey RW, Pinder SE, Ball GR, et al. Reading the prognosis of the individual with breast cancer. Eur J Cancer. 2007;43:1545–1547
  8. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long term follow-up. Histopathology. 1991;19:403–410
  9. Macmillan RD, Barbera D, Hadjiminas DJ, et al. Sentinel node biopsy for breast cancer may have little to offer four-node samplers: results of comparison study. EJC. 2001;37:1076–1080
  10. Weigelt B, Hu Z, He X, et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res. 2005;65(20):9155–9158
  11. Pereira H, Pinder SE, Sibbering DM, et al. Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology. 1995;27:219–226
  12. Diab SG, Clark GM, Osborne CK, et al. Tumour characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol. 1999;17:1442–1448
  13. Balslev I, Axelsson CK, Zedeler K, et al. The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat. 1994;32(3):1837–1841
  14. Ries LAG, Young JL, Keel GE, et al., editors. SEER survival monograph: cancer survival among adults: U.S. SEER Program, 1988–2001, patient and tumor characteristics. National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD; 2007.
  15. Early Breast Cancer Trialists’ Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998; 351:1451–67.
  16. Early Breast Cancer Trialists’ Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 1998; 352:930–42.
  17. Maynard PV, Griffiths K, Davies CJ, Elston CW, Blamey RW. The relationships between oestrogen receptor content, histological grade in human primary breast tumours. Br J Cancer. 1978;38:745
  18. D’Eredita G, Martellotta M, Natale T, Ferrarese F. Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long term follow-up and treated in a single institution. Eur J Cancer. 2001;37:591–596
  19. Lundin J. The Nottingham Prognostic Index – from relative to absolute risk prediction. Eur J Cancer. 2007;43:1498–1500[editorial comment]
  20. Joensuu H, Lehtimöki T, Holli K, et al. Risk of distant recurrence of breast cancer detected by mammography screening or other methods. JAMA. 2004;292(9):1967–1973

PII: S0959-8049(09)00681-9

doi: 10.1016/j.ejca.2009.09.009

European Journal of Cancer
Volume 46, Issue 1 , Pages 56-71 , January 2010

Article Tools

* Image Usage & Resolution